Clinical trials
Phase 3 Hypertension trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2012 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 4 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| KBP Biosciences | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Population Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 10 |
| Cardiovascular Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Essential Hypertension | 1 |
| Heart Diseases | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.